FDA Import Refusal 799-3402182-1/10003/1 — Glaxosmithkline Pharmaceuticals

Glaxosmithkline Pharmaceuticals — FEI 3004459800

The FDA refused shipment 799-3402182-1/10003/1 from Glaxosmithkline Pharmaceuticals (India) on Feb 6, 2026. The refused product falls under Drugs and Biologics — BETAMETHASONE VALERATE (GLUCOCORTICOID). Cited charge: 75 This firm has 5 or more other import refusals on record.